摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-羟基-4-(2-甲氧基苯基)哌啶-1-羧酸叔丁酯 | 201609-28-1

中文名称
4-羟基-4-(2-甲氧基苯基)哌啶-1-羧酸叔丁酯
中文别名
1-Boc-4-(2-甲氧基苯基)-4-哌啶醇
英文名称
tert-butyl 4-hydroxy-4-(2-methoxyphenyl)piperidine-1-carboxylate
英文别名
1-t-Butoxycarbonyl-4-hydroxy-4-(2-methoxyphenyl)piperidine;tert-butyl 4-hydroxy-4-(2-methoxyphenyl)-1-piperidinecarboxylate;1-Boc-4-(2-methoxyphenyl)-4-hydroxypiperidine
4-羟基-4-(2-甲氧基苯基)哌啶-1-羧酸叔丁酯化学式
CAS
201609-28-1
化学式
C17H25NO4
mdl
——
分子量
307.39
InChiKey
BVCNYTQHKRSBMX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    441.8±45.0 °C(Predicted)
  • 密度:
    1.145±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.59
  • 拓扑面积:
    59
  • 氢给体数:
    1
  • 氢受体数:
    4

SDS

SDS:ea8fecc45a050a77cfdd8ad1b86cb0b7
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Tetrahydrobenzindole compounds
    申请人:Meiji Seika Kaisha, Ltd.
    公开号:US06355642B1
    公开(公告)日:2002-03-12
    A compound of formula (I) for use in the treatment or prevention of mental diseases A is N, CH, C having a double bond or CR5; each of B and Z is independently N, CH or CR1, with the proviso that A is N when B and/or Z is N; R1, R2, R3, R4 and R5 and n are as defined in the specification.
    一种具有式(I)的化合物,用于治疗或预防精神疾病 其中,A为N、CH、C具有双键或CR5;B和Z中的每一个独立地为N、CH或CR1,但A为N时,B和/或Z为N;R1、R2、R3、R4和R5以及n的定义如规范中所述。
  • Bulky <i>N</i> ‐Heterocyclic‐Carbene‐Coordinated Palladium Catalysts for 1,2‐Addition of Arylboron Compounds to Carbonyl Compounds
    作者:Yuta Okuda、Masahiro Nagaoka、Tetsuya Yamamoto
    DOI:10.1002/cctc.202001464
    日期:2020.12.16
    primary, secondary, and tertiary alcohols by the 1,2‐addition of arylboronic acids or boronates to carbonyl compounds, including unactivated ketones, using novel bulky yet flexible N‐heterocyclic carbene (NHC)‐coordinated 2,6‐di(pentan‐3‐yl)aniline (IPent)‐based cyclometallated palladium complexes (CYPs) as catalysts is reported. The PhS‐IPent‐CYP‐catalyzed reactions are efficient at low catalyst loadings
    使用新型但又灵活的N杂环卡宾(NHC)配位的2,6-di(据报道以戊烷-3-基)苯胺(IPent)为基的环金属化钯配合物(CYPs)。PhS-IPent-CYP催化的反应在低催化剂负载量(0.02-0.3 mol%Pd)下有效,而1,2-加成的出色催化活性归因于NHC配体的空间体积。这些反应可产生各种功能化的苄醇,这些化合物很难通过经典方案使用高活性有机镁或锂试剂进行合成。
  • TETRAHYDROBENZINDOLE COMPOUNDS
    申请人:MEIJI SEIKA KAISHA LTD.
    公开号:EP0937715A1
    公开(公告)日:1999-08-25
    Since the compound of the present invention represented by the following formula (I) can strongly inhibit bonding of [3H]-serotonin and [3H]-5-CT to human serotonin 5-HT7 receptor subtype expressed in cultured cell line, the compound of formula (I) and pharmaceutically acceptable salts thereof can provide pharmaceutical conpositions for use in the treatment or prevention of mental diseases. [In the above formula, A is N, CH, C having a double bond or CR5; each of B and Z is independently N, CH or CR1, with the proviso that A is N when B and/or Z is N; R1 is a hydrogen atom, a halogen atom, a lower alkyl group, a cyano group, a trihalomethyl group, a hydroxy group, an alkoxy group, an alkylthio group, an alkylsulfinyl group, an alkylsulfonyl group, an alkoxycarbonyl group, a sulfamoyl group, an amino group, a substituted amino group, a carbamoyl group, an alkylcarbamoyl group, an acyl group or a carboxy group; R2 is a hydrogen atom or a lower alkyl group; R3 is a hydrogen atom, a lower alkyl group or an aralkyl group; R4 is a hydrogen atom, a halogen atom, a lower alkyl group, a hydroxy group, an alkoxy group, an acyl group, an alkoxycarbonyl group, a nitro group, an amino group, a substituted amino gropup, a carbamoyl group, an alkylcarbamoyl group or an acyloxy group; R5 is a lower alkyl group, a cyano group, a carbamoyl group, a carboxy group, an acyl group, an acyloxy group, an alkoxy group, an alkoxycarbonyl group, a trihalomethyl group or a hydroxy group; and n is an integer of 2 to 6.]
    由于下式(I)表示的本发明化合物能强烈抑制[3H]-serotonin和[3H]-5-CT与培养细胞系中表达的人5-羟色胺5-HT7受体亚型的结合,因此式(I)化合物及其药学上可接受的盐可提供用于治疗或预防精神疾病的药物组合。 [在上式中,A 是 N、CH、具有双键的 C 或 CR5;B 和 Z 各自独立地是 N、CH 或 CR1,但当 B 和/或 Z 是 N 时,A 是 N;R1 是氢原子、卤素原子、低级烷基、氰基、三卤甲基、羟基、烷氧基、烷硫基、烷基亚磺酰基、烷基磺酰基、烷氧基羰基、氨基磺酰基、氨基、取代氨基、氨基甲酰基、烷基氨基甲酰基、酰基或羧基; R2 是氢原子或低级烷基;R3 是氢原子、低级烷基或芳烷基; R4 是氢原子、卤素原子、低级烷基、羟基、烷氧基、酰基、烷氧羰基、硝基、氨基、取代氨基丙基、氨基甲酰基、烷基氨基甲酰基或酰氧基;R5 是低级烷基、氰基、氨基甲酰基、羧基、酰基、酰氧基、烷氧基、烷氧羰基、三卤甲基或羟基;以及 n 是 2 至 6 的整数。]
  • US6355642B1
    申请人:——
    公开号:US6355642B1
    公开(公告)日:2002-03-12
  • Ni-catalysed, domino synthesis of tertiary alcohols from secondary alcohols
    作者:Christophe Berini、Oscar Navarro
    DOI:10.1039/c1cc10826c
    日期:——
    The use of in situ generated (NHC)-Ni catalytic species (NHC = N-heterocyclic carbene) allows for the synthesis, in short reaction times, of a variety of tertiary alcohols from secondary alcohols through a domino oxidation-addition protocol.
    利用原位生成的(NHC)-Ni催化物种(NHC = N-杂环卡宾)可以在较短的反应时间内,通过串联氧化加成策略,从二级醇合成多种三级醇。
查看更多